THE ECSTASY AND RELATED DRUGS REPORTING SYSTEM 2017 KEY FINDINGS

October 13, 2017

THE ECSTASY AND RELATED DRUGS REPORTING SYSTEM 2017 KEY FINDINGS

The Ecstasy and Related Drugs Reporting System (EDRS) is an annual study that monitors trends in price, purity and availability of a range substances and attempts to identify trends and changes in the drug market. The EDRS involves interviews with regular drug users, as well as interviews with key informants from the sector. There is a Queensland component, which is one of the few studies that provides insight in local drug trends. The 2017 EDRS key findings included a significant decline in use of 'any' methamphetamine, with a particularly significant decrease in the use of crystal methamphetamine. Ecstasy use remained stable and the ecstasy market continued to diversify in 2017.  Pills were the most common form of MDMA used, however there were significant increases in the use of MDMA crystal, capsules and powder.  Another interesting trend was an increase in the use of magic mushrooms, LSD, ketamine and DMT, although the frequency of use was low.


Go to the 2017 Ecstasy and Related Drugs Preliminary findings